Cereno Scientific

"We are very pleased with our significant progress with the development off CS014 and happy to execute the final milestone payment for CS014 to Emeriti Bio."

"Our collaboration with Emeriti over the past five years has been very fruitful and we are excited to now have entered the clinical stage of development" (Sten R. Sörensen, CEO, Cereno Scientific)

Vicore Pharma

A close collaboration with Emeriti Bio and HalaCore Pharma, two experienced groups with unique knowledge of AT2 chemistry , has generated several series of novel molecules where the most promising will be selected for further development.